Challenges and emerging issues in patenting nanomedicines

Patenting Nanomedicines: Legal Aspects, Intellectual Property and Grant Opportunities

Volumn 9783642292651, Issue , 2012, Pages 25-48

  Murthy, Rayasa S Ramachandra ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Nanomedicine; Nanotechnology; Patenting; Patents

Indexed keywords

EID: 84949178418     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-29265-1_2     Document Type: Chapter

References (41)

1. Agreement on Trade-Related Aspects of Intellectual Property Rights (2011) Article 27.1
2. Agreement on Trade-Related Aspects of Intellectual Property Rights (2011) Article 33
3. Ajayan PM (1999) Nanotubes from carbon. Chem Rev 99(7): 1787-1800
4. Baker S, Aston A (2005) The business of nanotech. Bus Week 14: 65-71
5. Bawa R (2004a) A comprehensive nanotechnology library in miniature: a review of the Springer Handbook of Nanotechnology. Nanotechnol Law Bus 1: 341-343
6. Bawa R (2004b) Nanotechnology patenting in the US. Nanotechnol Law Bus 1: 31-50
7. Bawa R (2004c) Nanotechnology patents and challenges. Patent Cafe. www.cafezine.com/index-article. Accessed February 2011
8. Bawa R (2004d) Nanotechnology patents and the US Patent Office. Small Times 4
9. Bawa R (2004e) Patenting nanotechnology inventions: challenges and opportunities. In: Proceedings of the Hawaii International Conference on Sciences, Honolulu, Hawaii
10. Bawa R (2005a) The impact of the US Patent Office on nanotechnology. http://www.rpitechnology.com/?action=static&page=Resources. Accessed July 2011
11. Bawa R (2005b) Will nanomedicine "patent land grab" thwart commercialization?". Nanomedicine 1: 346-350
12. Bawa R, Bawa SR (2005) Protecting new inventions in nanomedicine. In: Wagner CG (ed) Foresight, innovation, and strategy: towards a wiser future. World Future Society, Bethesda
13. Bawa R, Maebius S, Iver C, Bawa SR (2005a) Biotechnology patents: challenges and opportunities. In: Bronzino JD (ed) The CRC biomedical engineering handbook. CRC Press, Boca Raton
14. Bawa R, Bawa SR, Maebius SB, Flynn T, Wei C (2005b) Protecting new ideas and inventions in nanomedicine via patents. Nanomedicine 1(2): 150-158
15. Bawa R, Bawa SR, Maebius S, Iver C (2006) Bionanotechnology patents: challenges and opportunities. In: Bronzino JD (ed) The biomedical engineering handbook. CRC Press, Boca Raton
16. Bawa R (2007a) Patents and nanomedicine. Nanomedicine 2(3): 351-374
17. Bawa R (2007b) The future of nanomedicine. In: Mack T (ed) Hopes and visions for the 21st century. World Future Society Press, Bethesda
18. EPODOC (2009) Database, 1993-2003
19. ETC (2005) Nanotech's "second nature" patents: implications for the global south. ETC Group, Ottawa
20. Forman D (2004) P storm clouds build on horizon. Small Times (May/Jun): 21-24
21. Freedonia (2007) Nanotechnology in healthcare. The Freedonia Group, Cleveland
22. Gordon E, Hall F (2005) Nanotechnology blooms, at last. Oncol Rep 13: 1003-1007
23. Huang Z, Chen H, Yip H, Ng G, Guo F, Chen ZK (2003) Longitudinal patent analysis for nanoscale science and engineering: country, institution and technology field. J Nanopart Res 5: 333-341
24. Hunt WH (2004) Nanomaterials: nomenclature, novelty and necessity. J Mater 56(10): 13-18, Oct
25. Kristof R, Benito B (2006) Nanomedicine: think big! Informa, London
26. Kubik T, Bogunia-Kubik K, Sugusaka M (2005) Nanotechnology on duty in medical applications. Curr Pharm Biotechnol 6: 17-33
27. Lux Research (2004a) Nanotechnology gold rush yields crowded, entangled patents. Lux Research, New York. http://www.prnewswire.com/news-releases/nanotechnology-gold-rush-yields-crowded-entangled-patents54373177.html. Accessed April 2011
28. Lux Research (2004) Sizing nanotechnology's value chain. Lux Research, New York
29. Miller JC, Serrato R, Represas-Cardenas JM, Kundahl G (2004) Handbook of nanotechnology business, policy and intellectual property law. Wiley, New York
30. NanoMarket Report (2007) Nanotechnology now. http://www.nanotech-now.com/new. Accessed September 2011
31. Niemeyer CM, Mirkin CA (2004) Nanobiotechnology-concepts, applications and prospectives. Wiley-VCH Verlag Gmbh & Co, Weinhelm
32. Oas B (2006) Life cycle management. Tablet and Capsules Oct: 12-20
33. Park C, Ounaies Z, Watson KA, Crooks RE, Smith J, Lowther SE, Connell JW, Siochi EJ, Harrison JS, Sta Clair TL (2002) Dispersion of single wall carbon nanotubes by in situ polymerization under sonication. Chem Phys Lett 364: 303-308
34. Paull R, Wolfe J, Hebert P, Sinkula M (2003) Investing in nanotechnology. Nat Biotechnol 21: 1144-1147
35. Regaled A (2004) Nanotechnology patents surge as companies vie to stake claim. Wall Street J Sect A: 1
36. Service R (2005) Nanotechnology takes aim at cancer. Science 310: 1132-1134
37. Shapiro C (2000) Navigating the patent thicket: cross licenses, patent pools, and standard-setting. Innovation Policy Econ 1: 119-150
38. Thassu D, Deleers M, Pathak Y (2007) Latest technologies related to nanoparticles in drug delivery. Nanoparticulate drug del systems. Informa Healthcare, New York
39. Vo-Dinh T (2007) Nanotechnology in biology and medicine-methods, devices and applications. CRC Press, Boca Raton
40. Wagner V, Dullaart A, Bock A, Zweck A (2006) The emerging nanomedicine landscape. Nat Biotechnol 24: 1211-1217
41. World Intellectual Property Organization (2009) Patents: frequently asked questions. http://www.wipo.int/patentscope/en/patents-faq.html#protection. Accessed February 2011